PLEASANTON, Calif., Aug. 8, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will announce financial results for its second quarter, which ended July 31, 2023, after market close on August 30, 2023. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results.
Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com approximately at 1:05 p.m. PT (4:05 p.m. ET). A webcast replay will be available on the website following the live event.
Event: | Veeva's Fiscal 2024 Second Quarter Results Conference Call |
Date: | Wednesday, August 30, 2023 |
Time: | 2:00 p.m. PT (5:00 p.m. ET) |
Conference Call Registration: | |
Webcast: |
About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Veeva uses its ir.veeva.com website as a means of disclosing material non-public information, announcing upcoming investor conferences, and for complying with its disclosure obligations under Regulation FD. Accordingly, you should monitor Veeva's investor relations website in addition to following its press releases, SEC filings, and public conference calls and webcasts.
Investor Relations Contact: | ||
Gunnar Hansen Veeva Systems Inc. 267-460-5839 This email address is being protected from spambots. You need JavaScript enabled to view it. |
Media Contact: | |
Maria Scurry | |
Veeva Systems Inc. | |
781-366-7617 | |
This email address is being protected from spambots. You need JavaScript enabled to view it. |
Last Trade: | US$281.35 |
Daily Change: | -2.85 -1.00 |
Daily Volume: | 982,787 |
Market Cap: | US$45.980B |
July 23, 2025 June 25, 2025 June 11, 2025 June 04, 2025 |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORERecursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREEnd of content
No more pages to load